Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Michael O’Dwyer, MD, PhD, National University of Ireland, Galway, Ireland, discusses how anti-CD38 CAR NK-cells could selectively target myeloma cells to minimize off-target toxicity. This video was recorded at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.